Simris Alg AB (publ) (SIMRIS-B.ST) Stock Analysis & Winston Score
Simris Alg AB is a Swedish biotechnology company that grows microalgae and turns them into natural ingredients. Its main products include omega-3 fatty acids and pigments derived from algae, sold to customers in the food supplement, cosmetics, and health product markets. The company positions itself as a sustainable alternative to fish-based omega-3 sources, which is a key part of its identity. Simris generates revenue by selling algae-based ingredients and finished consumer products, primarily in Sweden and other European markets. It is a very small company, and its deeply negative gross and operating margins show it is spending far more than it earns right now. The main growth driver is rising consumer demand for plant-based and sustainable health products, but the biggest risk is that the company may struggle to scale production efficiently enough to become profitable before it runs out of funding.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (1/30)
- Growth: Good (10/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (8/15)
Key Facts
Price: 0.10 SEK
Market Cap: 133M SEK
Sector: Healthcare
Industry: Biotechnology
Exchange: Stockholm Stock Exchange
